Difference between revisions of "Tumour-infiltrating lymphocytes"

Jump to navigation Jump to search
Line 11: Line 11:
|-
|-
| [[Colorectal carcinoma]]  
| [[Colorectal carcinoma]]  
| [[Microsatellite instability in colorectal cancer|microsatellite instability]]<ref name=pmid21114775>{{Cite journal  | last1 = Iacopetta | first1 = B. | last2 = Grieu | first2 = F. | last3 = Amanuel | first3 = B. | title = Microsatellite instability in colorectal cancer. | journal = Asia Pac J Clin Oncol | volume = 6 | issue = 4 | pages = 260-9 | month = Dec | year = 2010 | doi = 10.1111/j.1743-7563.2010.01335.x | PMID = 21114775 }}</ref>
| TILs associated with [[Microsatellite instability in colorectal cancer|microsatellite instability]]<ref name=pmid21114775>{{Cite journal  | last1 = Iacopetta | first1 = B. | last2 = Grieu | first2 = F. | last3 = Amanuel | first3 = B. | title = Microsatellite instability in colorectal cancer. | journal = Asia Pac J Clin Oncol | volume = 6 | issue = 4 | pages = 260-9 | month = Dec | year = 2010 | doi = 10.1111/j.1743-7563.2010.01335.x | PMID = 21114775 }}</ref>
|-
|-
| [[Malignant melanoma]]  
| [[Malignant melanoma]]  
|
| TILs better survivall<ref>{{Cite journal  | last1 = Lee | first1 = N. | last2 = Zakka | first2 = LR. | last3 = Mihm | first3 = MC. | last4 = Schatton | first4 = T. | title = Tumour-infiltrating lymphocytes in melanoma prognosis and cancer immunotherapy. | journal = Pathology | volume = 48 | issue = 2 | pages = 177-87 | month = Feb | year = 2016 | doi = 10.1016/j.pathol.2015.12.006 | PMID = 27020390 }}</ref>
|-
|-
|[[Non-small cell lung cancer]]  
|[[Non-small cell lung cancer]]  
| associated with anti-[[PD-L1]] response<ref name=pmid26970723>{{Cite journal  | last1 = Fehrenbacher | first1 = L. | last2 = Spira | first2 = A. | last3 = Ballinger | first3 = M. | last4 = Kowanetz | first4 = M. | last5 = Vansteenkiste | first5 = J. | last6 = Mazieres | first6 = J. | last7 = Park | first7 = K. | last8 = Smith | first8 = D. | last9 = Artal-Cortes | first9 = A. | title = Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial. | journal = Lancet | volume =  | issue =  | pages =  | month = Mar | year = 2016 | doi = 10.1016/S0140-6736(16)00587-0 | PMID = 26970723 }}</ref>
| TILs associated with anti-[[PD-L1]] response<ref name=pmid26970723>{{Cite journal  | last1 = Fehrenbacher | first1 = L. | last2 = Spira | first2 = A. | last3 = Ballinger | first3 = M. | last4 = Kowanetz | first4 = M. | last5 = Vansteenkiste | first5 = J. | last6 = Mazieres | first6 = J. | last7 = Park | first7 = K. | last8 = Smith | first8 = D. | last9 = Artal-Cortes | first9 = A. | title = Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial. | journal = Lancet | volume =  | issue =  | pages =  | month = Mar | year = 2016 | doi = 10.1016/S0140-6736(16)00587-0 | PMID = 26970723 }}</ref>
|-
|-
| [[Ovarian serous carcinoma]]
| [[Ovarian serous carcinoma]]
| good prognosis<ref name=pmid26972336>{{Cite journal  | last1 = Webb | first1 = JR. | last2 = Milne | first2 = K. | last3 = Kroeger | first3 = DR. | last4 = Nelson | first4 = BH. | title = PD-L1 expression is associated with tumor-infiltrating T cells and favorable prognosis in high-grade serous ovarian cancer. | journal = Gynecol Oncol | volume = 141 | issue = 2 | pages = 293-302 | month = May | year = 2016 | doi = 10.1016/j.ygyno.2016.03.008 | PMID = 26972336 }}</ref>
| TILs associated with good prognosis<ref name=pmid26972336>{{Cite journal  | last1 = Webb | first1 = JR. | last2 = Milne | first2 = K. | last3 = Kroeger | first3 = DR. | last4 = Nelson | first4 = BH. | title = PD-L1 expression is associated with tumor-infiltrating T cells and favorable prognosis in high-grade serous ovarian cancer. | journal = Gynecol Oncol | volume = 141 | issue = 2 | pages = 293-302 | month = May | year = 2016 | doi = 10.1016/j.ygyno.2016.03.008 | PMID = 26972336 }}</ref>
|-
|-
|}
|}
48,833

edits

Navigation menu